Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study (Q72518511)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference

J. Galdi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119718

8 August 2023

R. O. Rieder

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119718

8 August 2023

D. Silber

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119718

8 August 2023

R. R. Bonato

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6119718

8 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6119718

8 August 2023

publication date

1 November 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0033291700041210

1 reference

https://api.crossref.org/works/10.1017/S0033291700041210

8 August 2023

published in

Psychological Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

713-728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

An investigation of the postpsychotic depressive syndrome

27 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depressive symptoms in Parkinson patients referred for thalamotomy

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Comparative Doses and Costs of Antipsychotic Medication

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depression and the reintegration phase of acute schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The problem of post-psychotic schizophrenic depressions and their pharmacological induction. Long-term studies with fluspirilene and penfluridol and single-blind trial with fluphenazine-decanoate and flupenthixol-decanoate

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Premorbid Asocial Adjustment and Response to Phenothiazine Treatment Among Schizophrenic Inpatients

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Fluphenazine and social therapy in the aftercare of schizophrenic patients. Relapse analyses of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Manic-Depressive Illness: A Comparative Study of Patients with and Without a Family History

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Psychoendocrinology of Ego Disintegration

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

'Akinetic Depression' in Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Drug response and psychiatric nosology

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depression following fluphenazine treatment.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Postpsychotic depression in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Diagnostic Criteria for Use in Psychiatric Research

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Biology of Schizophrenia Subtypes: A Review and Proposal for Method of Study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

A Study of Pairs of Sibs both Hospitalized for Mental Disorder

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Severe Depressive Mood Changes Following Slow-release Intramuscular Fluphenazine Injection

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The Validity of Good Prognosis Schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Accuracy of the family history method in affective illness. Comparison with direct interviews in family studies

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Genetic Determinants of Borderline Conditions*

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

NOSIE-30: A Treatment-Sensitive Ward Behavior Scale

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Neuroleptic Drugs and the Prevention of Relapse in Schizophrenia: A Workshop Report

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Research diagnostic criteria: rationale and reliability

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Overview of recent research in depression. Integration of ten conceptual models into a comprehensive clinical frame

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The schizophrenic patient and depressive symptomatology

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depression in acute schizophrenic psychosis

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

A ward behavior rating scale for mental hospital patients.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The classification of the functional psychoses.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The inheritance of affective disorders: A review of data and of hypotheses

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depressive syndrome in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

A critical review of recent adoption, twin, and family studies of schizophrenia: behavioral genetics perspectives

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Postpsychotic state, convalescent environment, and therapeutic relationship in schizophrenic outcome

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The pathophysiology of extrapyramidal side-effects of neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Genetic strategies in biological psychiatry.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

The treatment of acute schizophrenia without drugs: an investigation of some current assumptions

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Postpsychotic depression and the need for personal significance

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depression in Patients with Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Depression in chronic paranoid schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

PSYCHOENDOCRINE ASPECTS OF ACUTE SCHIZOPHRENIC REACTIONS

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Antischizophrenic drugs and brain cholinergic receptors. Affinity for muscarinic sites predicts extrapyramidal effects

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700041210

7 January 2021

Neuroleptic induced extrapyramidal symptoms

17

1 reference

https://api.crossref.org/works/10.1017/S0033291700041210

Third Psychoactive Drug Usage Guide

8 August 2023

30

1 reference

https://api.crossref.org/works/10.1017/S0033291700041210

Is a familial definition of depression both feasible and valid?

8 August 2023

37

1 reference

https://api.crossref.org/works/10.1017/S0033291700041210

Dysphoric response to neuroleptic treatment in schizophrenia and its prognostic significance

8 August 2023

91

1 reference

https://api.crossref.org/works/10.1017/S0033291700041210

Dysphoric response to neuroleptic treatment in schizophrenia: its relationship to autonomic arousal and prognosis

8 August 2023

92

1 reference

https://api.crossref.org/works/10.1017/S0033291700041210

8 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6119718%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference